SCHEMBL6315934

SCHEMBL6315934

NCc1cc([N+](=O)[O-])ccc1N1CCN(Cc2ccccc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
LMNA P02545 3/20 0.62
CYP2C19 P33261 2/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2C9 P11712 1/20 0.61
MAPT P10636 4/20 0.55
NPBWR1 P48145 1/20 0.55
MCHR1 Q99705 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.51
TDP1 Q9NUW8 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
KDM4E B2RXH2 2/20 0.50
TRPV6 Q9H1D0 1/20 0.50
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
GFER P55789 1/20 0.49
KMT2A Q03164 1/20 0.49
MAPK1 P28482 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6269637 0.84 ALDH1A1 (0.60) ALDH1A1LMNACYP2C19CYP3A4CYP2C9
SCHEMBL6599900 0.83 ALDH1A1 (0.65) ALDH1A1LMNACYP2C19CYP3A4CYP2C9
SCHEMBL6449799 0.83 ALDH1A1 (0.64) ALDH1A1LMNACYP2C19CYP3A4CYP2C9
SCHEMBL7985192 0.81 ALDH1A1 (0.62) ALDH1A1LMNACYP2C19CYP3A4CYP2C9
SCHEMBL5393900 0.81 LMNA (0.67) ALDH1A1LMNACYP2C19CYP3A4CYP2C9
SCHEMBL3957309 0.80 ALDH1A1 (0.70) ALDH1A1LMNACYP2C19CYP3A4CYP2C9
SCHEMBL19212110 0.80 ALDH1A1 (0.61) ALDH1A1LMNACYP2C19CYP3A4CYP2C9
SCHEMBL3201205 0.79 ALDH1A1 (0.60) ALDH1A1LMNACYP2C19CYP3A4CYP2C9
SCHEMBL16824840 0.79 ALDH1A1 (0.53) ALDH1A1LMNACYP2C19CYP3A4MAPT
SCHEMBL5391586 0.78 ALDH1A1 (0.63) ALDH1A1LMNACYP2C19CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936715-B2 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (FR) 2005-08-30 US disclosed
EP-1265891-B1 NOVEL LIPOIC ACID HETEROCYCLIC OR BENZENE DERIVATIVES, PREPARATION AND USE THEREOF AS MEDICINES CONSEILS DE RECH SET D APPLIC (FR) 2004-12-29 EP disclosed
US-20030105107-A1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines IPSEN PHARMA S.A.S. (FR) 2003-06-05 US disclosed
EP-1265891-A2 NOVEL LIPOIC ACID HETEROCYCLIC OR BENZENE DERIVATIVES, PREPARATION AND USE THEREOF AS MEDICINES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-12-18 EP disclosed
WO-2001068643-A2 NOVEL LIPOIC ACID HETEROCYCLIC OR BENZENE DERIVATIVES, PREPARATION AND USE THEREOF AS MEDICINES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2001-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105107-A1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines LTC4S, LPO, COASY ALDH1A1 329/4885LMNA 990/4885CYP2C19 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.